The Methyl-CpG-Binding Protein Mbd2 Regulates Susceptibility to Experimental Colitis via Control of CD11c(+) Cells and Colonic Epithelium

Methyl-CpG-binding domain-2 (Mbd2) acts as an epigenetic regulator of gene expression, by linking DNA methylation to repressive chromatin structure. Although Mbd2 is widely expressed in gastrointestinal immune cells and is implicated in regulating intestinal cancer, anti-helminth responses and colon...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Immunol
Huvudupphovsmän: Jones, Gareth-Rhys, Brown, Sheila L., Phythian-Adams, Alexander T., Ivens, Alasdair C., Cook, Peter C., MacDonald, Andrew S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2020
Ämnen:
Immunology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033935/
https://ncbi.nlm.nih.gov/pubmed/32117307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00183
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk